Skip to main content

Table 1 Summary of the datasets used

From: Level of neo-epitope predecessor and mutation type determine T cell activation of MHC binding peptides

Source

HLA

Total no. of predicted samples

Confirmed Positive samples

Confirmed Negative samples

Melanoma (Me.)

A*02:01

485

35

450

Melanoma Patient 1

A*02

B*18, B*35

C*07, C*05

187

7

180

Melanoma Patient 2

A*11, A*23

B*14, B*41

56

3

53

Melanoma Patient 3

A*02, A*24

B*15, B*38

68

3

65

Tantigen [44]

mix

 

24

0

  1. For each dataset the name of the dataset, the number of positives and negatives epitopes in the data, and the HLA composition of the data are presented. The Melanoma patients were used for validation of the model and the results
Back to article page